Ultralife (ULBI) Cost of Revenue (2010 - 2026)

Ultralife's Cost of Revenue history runs 17 years deep, the most recent figure standing at $37.3 million for Q1 2026.

• On a quarterly basis, Cost of Revenue fell 1.75% year-over-year to $37.3 million in Q1 2026; TTM through Mar 2026 was $144.5 million, a 49.63% increase from a year earlier, with the FY2025 full-year figure at $145.1 million, up 18.83% from the prior year.
• Cost of Revenue improved to $37.3 million in Q1 2026 per ULBI's latest filing, from $36.4 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $38.0 million in Q1 2025 and bottomed at $120000.0 in Q4 2024.
• The 5-year median for Cost of Revenue is $30.5 million (2024), against an average of $29.0 million.
• Across the five-year window, Cost of Revenue tumbled 99.64% in 2024 and jumped 30254.17% in 2025, its largest moves.
• Year by year, Cost of Revenue stood at $28.0 million in 2022, then rose by 18.27% to $33.1 million in 2023, then tumbled by 99.64% to $120000.0 in 2024, then soared by 30254.17% to $36.4 million in 2025, then gained by 2.5% to $37.3 million in 2026.
• Per Business Quant, the three latest ULBI Cost of Revenue figures stand at $37.3 million (Q1 2026), $36.4 million (Q4 2025), and $33.8 million (Q3 2025).